Anchoring the Industry's Future - TCL PV Tech Showcases Five Business Matrices at SNEC 2025
SHANGHAI, June 11, 2025 /PRNewswire/ -- On June 11, 2025, the 18th SNEC (2025) PV POWER & ES EXPO, a premier event in the global photovoltaic industry, grandly opened at the National Exhibition and Convention Center in Shanghai. Under the theme...
![G-DRAGON 2025 WORLD TOUR [Übermensch] IN MACAU, presented by Galaxy Macau™](http://prnewswire.vietreader.com/thumb/190x300/2025-06/g-dragon-2025-world-tour-ubermensch-in-macau-presented-by-galaxy-macau-1.jpg)
G-DRAGON 2025 WORLD TOUR [Übermensch] IN MACAU, presented by Galaxy Macau™
QQ MUSIC Attracts Over 7 Million Simultaneous Users, with G-DRAGON's Electrifying Three-Night Live Performance SHENZHEN, China, June 10, 2025 /PRNewswire/ -- Promoted by AEG Presents, TME live and Chessman, G-DRAGON 2025 WORLD TOUR [Übermensch] IN...
CCTV+: 64 Years of China-Japan Friendship Marked by a Bottle of Moutai
Table tennis champion Matsuzaki Kimiyo recalls receiving the iconic gift from Premier Zhou Enlai in 1961 BEIJING, June 7, 2025 /PRNewswire/ -- A timeworn bottle of Moutai takes pride of place at Expo 2025 Osaka's China Pavilion, telling a story of...
NEFECON®: New Results at ERA 2025 Demonstrate Treatment Benefit of the 'Treat Early' Strategy
Two new studies on NEFECON® demonstrate its treatment benefit in the "Treat Early" strategy for IgA nephropathy (IgAN), providing robust support for the new disease management strategy: "Treat the Cause, Treat Early, Treat All": — A subanalysis of...
Odoo's Tokyo DX Seminar Highlights Strong Interest in Next-Generation Global ERP
TOKYO, June 6, 2025 /PRNewswire/ -- Cloud-based integrated ERP (Enterprise Resource Planning) solution Odoo, together with official partners ALUBENA, Falinwa, Portcities Japan, and customer METER Japan, successfully held a DX Seminar in Akasaka,...
Highlights in Oral Presentation of Mabwell's 9MW2821 at 2025 ASCO
SHANGHAI, June 5, 2025 /PRNewswire/ -- At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, USA, from May 30 to June 3, the results of the Phase Ib/II clinical study of 9MW2821 in combination with Toripalimab for...
Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting
SHANGHAI and CHICAGO, June 5, 2025 /PRNewswire/ -- The 2025 ASCO Annual Meeting is taking place in Chicago, US, from May 30 to June 3. Duality Bio (HKEX: 9606.HK) presented the preliminary data of two clinical trials, HER3 ADC candidate DB-1310 and...
Innovent's IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, June 5, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...
Witness the power of images to change the world: The First SmallRig Awards Announce 22 Global Winners
SHENZHEN, China, June 4, 2025 /PRNewswire/ -- The 2025 International Image Culture Week kicked off in Shenzhen with the highly anticipated 2025 SmallRig Awards Ceremony, where 22 prestigious awards were presented to exceptional global creators. The...
"Xiamen Day" Successfully Held at Expo 2025 Osaka China Pavilion, Fostering a New Era of Multifaceted Collaboration
OSAKA, Japan, June 3, 2025 /PRNewswire/ -- From May 31 to June 1, 2025, "Xiamen Day" captivated audiences at the China Pavilion of Expo 2025 Osaka. Under the theme "Facing the Sea, Flowers Blooming in Four Seasons" and guided by the principles of...